The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.
Glioma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–264 of 264
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q
Baroni, L., Sundaresan, L., Heled, A., Coltin, H., Pajtler, K. W., Lin, T., Merchant, T. E., McLendon, R. E., Faria, C. C., Buntine, M. K., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab034 · Cited by 94
Natsume, A., Arakawa, Y., Narita, Y., Sugiyama, K., Hata, N., Muragaki, Y., Shinojima, N., Kumabe, T., Saito, R., Motomura, K., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noac155 · Cited by 93
Tabrizi, S., Yeap, B. Y., Sherman, J. C., Nachtigall, L. B., Colvin, M. K., Dworkin, M., Fullerton, B. C., Daartz, J., Royce, T. J., Oh, K. S., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.04.027 · Cited by 93
Infratentorial IDH-mutant astrocytoma is a distinct subtype
Banan, R., Stichel, D., Bleck, A. C., Hong, B., Lehmann, U., Suwala, A. K., Reinhardt, A., Schrimpf, D., Buslei, R., Stadelmann, C., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02194-y · Cited by 91
de la Fuente, M. I., Colman, H., Rosenthal, M. A., Tine, B. A. V., Levacic, D., Walbert, T., Gan, H. K., Vieito, M., Milhem, M. M., Lipford, K., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac139 · Cited by 91
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle
Goode, B., Mondal, G., Hyun, M., Ruiz, D. G., Lin, Y.-H. T., Ziffle, J. V., Joseph, N. M., Onodera, C. S., Talevich, E., Grenert, J. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02826-8 · Cited by 89
Armstrong, T. S., Dirven, L., Arons, D. F., Bates, A., Chang, S. M., Coens, C., Espinasse, C., Gilbert, M. R., Jenkinson, D., Kluetz, P. G., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30796-x · Cited by 89
Self-citationRapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study
Patel, A., Dogan, H., Payne, A., Krause, E., Sievers, P., Schoebe, N., Schrimpf, D., Blume, C., Stichel, D., Holmes, N., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02415-6 · Cited by 88
Girardi, F., Matz, M., Stiller, C. A., You, H., Gragera, R. M., Valkov, М. Y., Bulliard, J., De, P., Morrison, D. S., Wanner, M., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac217 · Cited by 88
Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience
Lassaletta, Á., Strother, D. R., Laperrière, N., Hukin, J., Vanan, M., Goddard, K., Lafay‐Cousin, L., Johnston, D. L., Zelcer, S. M., Zápotocký, M., et al. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.26988 · Cited by 85
Sievers, P., Henneken, S. C., Blume, C., Sill, M., Schrimpf, D., Stichel, D., Okonechnikov, K., Reuß, D., Benzel, J., Maaß, K. K., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02356-6 · Cited by 85
Self-citationA noncoding single-nucleotide polymorphism at 8q24 drives IDH1 -mutant glioma formation
Yanchus, C., Drucker, K. L., Kollmeyer, T. M., Tsai, R., Winick‐Ng, W., Liang, M., Malik, A., Pawling, J., Lorenzo, S. B. D., Ali, A., et al. (2022) · Science · doi:10.1126/science.abj2890 · Cited by 84
Coomans, M. B., Dirven, L., Aaronson, N. K., Baumert, B. G., van den Bent, M. J., Bottomley, A., Brandes, A. A., Chinot, O. L., Coens, C., Gorlia, T., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz118 · Cited by 83
Self-citationMolecular Biomarker Testing for the Diagnosis of Diffuse Gliomas
Brat, D. J., Aldape, K., Bridge, J. A., Canoll, P., Colman, H., Hameed, M. R., Harris, B. T., Hattab, E. M., Huse, J. T., Jenkins, R. B., et al. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0295-cp · Cited by 82
Pe, M. L., Alanya, A., Falk, R. S., Amdal, C. D., Bjordal, K., Chang, J., Cislo, P. R., Coens, C., Dirven, L., Speck, R. M., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00157-2 · Cited by 79
Self-citationZFTA Translocations Constitute Ependymoma Chromatin Remodeling and Transcription Factors
Kupp, R., Ruff, L., Terranova, S., Nathan, E., Ballereau, S. J., Stark, R., Chilamakuri, C. S. R., Hoffmann, N., Wickham-Rahrmann, K., Widdess, M. A., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1052 · Cited by 78
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study
Lassman, A. B., Sepúlveda-Sánchez, J. M., Cloughesy, T. F., Gil‐Gil, M., Puduvalli, V. K., Raizer, J. J., Vos, F. D., Wen, P. Y., Butowski, N. A., Clément, P. M., et al. (2022) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-230044 · Cited by 76
Self-citationRudà, R., Capper, D., Waldman, A. D., Pallud, J., Minniti, G. C., Kaley, T. J., Bouffet, É., Tabatabai, G., Aronica, E., Jakola, A. S., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac188 · Cited by 76
Self-citationAn activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice
Gronych, J., Korshunov, A., Bageritz, J., Milde, T., Jugold, M., Hambardzumyan, D., Remke, M., Hartmann, C. J., Witt, H., Jones, D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44656 · Cited by 75
Guerrini‐Rousseau, L., Varlet, P., Colas, C., Andreiuolo, F. D. M., Bourdeaut, F., Dahan, K., Devalck, C., Faure‐Conter, C., Genuardi, M., Goldberg, Y., et al. (2019) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdz033 · Cited by 75
Iorgulescu, J. B., Sun, C., Neff, C., Cioffi, G., Gutierrez, C., Kruchko, C. A., Ruhl, J., Waite, K. A., Negoita, S., Hofferkamp, J., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac113 · Cited by 75
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Das, A., Tabori, U. Y., Nahum, L. C. S., Collins, N. B., Deyell, R. J., Dvir, R., Faure‐Conter, C., Hassall, T., Minturn, J. E., Edwards, M., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0411 · Cited by 74
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas
Rosenberg, S., Simeonova, I., Bielle, F., Verreault, M., Bance, B., Roux, I. L., Daniau, M., Nadaradjane, A. A., Gleize, V., Paris, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04622-w · Cited by 73
Oligosarcomas, IDH-mutant are distinct and aggressive
Suwala, A. K., Felix, M., Friedel, D., Stichel, D., Schrimpf, D., Hinz, F. E., Hewer, E., Schweizer, L., Dohmen, H., Pohl, U., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02395-z · Cited by 72
Gilbert, M. R., Yuan, Y., Wu, J., Mendoza, T. R., Vera, E. M., Omuro, A. M. P., Lieberman, F. S., Robins, H. I., Gerstner, E. R., Wu, J., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa240 · Cited by 71
Self-citationUmemura, Y., Orringer, D. A., Junck, L., Varela, M. L., West, M. E. J., Faisal, S. M., Comba, A., Heth, J., Sagher, O., Leung, D., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00347-9 · Cited by 70
Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma
DeSisto, J. A., Lucas, J. T., Xu, K., Donson, A. M., Lin, T., Sanford, B. L., Wu, G., Tran, Q. T., Hedges, D. J., Hsu, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25709-x · Cited by 67
Eigenbrod, S., Trabold, R., Brucker, D., Erös, C., Egensperger, R., la Fougère, C. J., Göbel, W., Rühm, A., Kretzschmar, H. A., Tonn, J. C., et al. (2014) · Acta Neurochirurgica · doi:10.1007/s00701-014-2073-1 · Cited by 65
Boele, F. W., Heimans, J. J., Aaronson, N. K., TAPHOORN, M. J. B., Postma, T. J., Reijneveld, J. C., & Klein, M. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1198-z · Cited by 65
Impact of atopy on risk of glioma: a Mendelian randomisation study
Disney–Hogg, L., Cornish, A. J., Sud, A., Law, P., Kinnersley, B., Jacobs, D. I., Ostrom, Q. T., Labrèche, K., Eckel‐Passow, J. E., Armstrong, G., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1027-5 · Cited by 65
Rahman, R. M., Trippa, L., Lee, E. Q., Arrillaga‐Romany, I., Fell, G. G., Touat, M., McCluskey, C. S., Wiley, J., Gaffey, S. C., Drappatz, J., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00493 · Cited by 64
Self-citationDeng, M. Y., Sturm, D., Pfaff, E., Sill, M., Stichel, D., Balasubramanian, G. P., Tippelt, S., Kramm, C. M., Donson, A. M., Green, A. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25708-y · Cited by 62
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma
Weller, M., Felsberg, J., Hentschel, B., Gramatzki, D., Kubon, N., Wolter, M., Reusche, M., Roth, P., Krex, D., Herrlinger, U., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02662-1 · Cited by 62
Self-citationCellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study
Schüz, J., Pirie, K. L., REEVES, G. K., Floud, S., Beral, V., & Collaborators, F. T. M. W. S. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac042 · Cited by 60
Cimino, P. J., Ketchum, C., Turakulov, R. I., Singh, O., Abdullaev, Z., Giannini, C., Pytel, P., Lopez, G. Y., Colman, H., Nasrallah, M. P., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02513-5 · Cited by 59
Dirven, L., Armstrong, T. S., Blakeley, J. O., Brown, P. D., Grant, R., Jalali, R., Leeper, H. E., Mendoza, T. R., Nayak, L., Reijneveld, J. C., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30004-4 · Cited by 58
Self-citationWefel, J. S., Armstrong, T. S., Pugh, S. L., Gilbert, M. R., Wendland, M. M. M., Brachman, D. G., Roof, K. S., Brown, P. D., CROCKER, I. R., Robins, H. I., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab011 · Cited by 58
Crowell, C., Mata‐Mbemba, D., Bennett, J., Matheson, K. J., Mackley, M. P., Perreault, S., & Erker, C. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac133 · Cited by 57
Jünger, S. T., Andreiuolo, F. D. M., Mynarek, M., Wohlers, I., Rahmann, S., Klein‐Hitpaß, L., Dörner, E., Mühlen, A. Z., Char, N. V., von Hoff, K., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02169-z · Cited by 54
The genomic landscape of familial glioma
Choi, D., Armstrong, G., Lozzi, B., Vijayaraghavan, P., Plon, S. E., Wong, T. C., Boerwinkle, E., Muzny, D. M., Chen, H., Gibbs, R. A., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade2675 · Cited by 52
Castaño‐Vinyals, G., Sadetzki, S., Vermeulen, R. C. H., Momoli, F., Kundi, M., Merletti, F., Maslanyj, M., Calderón, C., Wiart, J., Lee, A.-K., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.107069 · Cited by 50
Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas
Wolter, M., Felsberg, J., Malzkorn, B., Kaulich, K., & Reifenberger, G. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01335-6 · Cited by 50
Self-citationSloan, E. A., Hilz, S., Gupta, R. K., Cadwell, C. R., Ramani, B., Hofmann, J. W., Kline, C., Banerjee, A., Reddy, A. T., Bush, N. A. O., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02144-8 · Cited by 48
Self-citationLook, T., Puca, E., Bühler, M., Kirschenbaum, D., Luca, R. D., Stucchi, R., Ravazza, D., Nitto, C. D., Roth, P., Katzenelenbogen, Y., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf2281 · Cited by 46
Self-citationMutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression
Pirozzi, C. J., Carpenter, A. B., Waitkus, M. S., Wang, C. Y., Zhu, H., Hansen, L. J., Chen, L. H., Greer, P. K., Feng, J., Wang, Y., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0485 · Cited by 44
Thomas, C., Thierfelder, F., Träger, M., Soschinski, P., Müther, M., Edelmann, D., Förster, A., Geiler, C., Kim, H., Filipski, K., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02300-8 · Cited by 44
The coming of age of liquid biopsy in neuro-oncology
Berzero, G., Pieri, V., Mortini, P., Filippi, M., & Finocchiaro, G. (2023) · Brain · doi:10.1093/brain/awad195 · Cited by 44
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas
Sweha, S. R., Chung, C., Natarajan, S. K., Panwalkar, P., Pun, M. J., Ghali, A., Bayliss, J. M., Pratt, D. W., Shankar, A., Ravikumar, V., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7860 · Cited by 43
Investigational PET tracers in neuro-oncology—What’s on the horizon? A report of the PET/RANO group
Galldiks, N., Langen, K., Albert, N. L., Law, I. G., Kim, M. M., Villanueva-Meyer, J. E., Soffietti, R., Wen, P. Y., Weller, M., & Tonn, J. C. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac131 · Cited by 43
Self-citationGirardi, F., Carlo, V. D., Stiller, C. A., Gatta, G., Woods, R. R., Visser, O. J., Lacour, B., Tucker, T. C., Coleman, M. P., Allemani, C., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac232 · Cited by 41
Environmental and sex-specific molecular signatures of glioma causation
Claus, E. B., Cannataro, V. L., Gaffney, S. G., & Townsend, J. P. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab103 · Cited by 40
Ebrahimi, A., Korshunov, A., Reifenberger, G., Capper, D., Felsberg, J., Trisolini, E., Pollo, B., Calatozzolo, C., Prinz, M., Staszewski, O., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01308-1 · Cited by 40
Self-citationBockmayr, M. L., Harnisch, K. J., Pohl, L., Schweizer, L., Mohme, T., Körner, M., Alawi, M., Suwala, A. K., Dorostkar, M. M., Monoranu, C. M., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac088 · Cited by 40
Stummer, W., Koch, R., Valle, R. D., Roberts, D. W., Sanai, N., Kalkanis, S., Hadjipanayis, C. G., & Molina, E. S. (2019) · Acta Neurochirurgica · doi:10.1007/s00701-019-04007-y · Cited by 35
Ida, C. M., Johnson, D. R., Nair, A., Davila, J. I., Kollmeyer, T. M., Minn, K. T., Fadra, N., Balcom, J. R., Fung, K.-M. A., Kim, D. K., et al. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab075 · Cited by 35
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C
Eckel‐Passow, J. E., Drucker, K. L., Kollmeyer, T. M., Kosel, M., Decker, P. A., Molinaro, A. M., Rice, T., Praska, C. E., Clark, L. E., Caron, A. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa117 · Cited by 32
Tesileanu, C. M. S., Vallentgoed, W., French, P. J., & van den Bent, M. J. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.08.016 · Cited by 32
Jo, J., Díaz, M., Horbinski, C., Mackman, N., Bagley, S. J., Broekman, M., Rak, J. W., Perry, J., Pabinger, I., Key, N. S., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad059 · Cited by 32
Kros, J. M., Rushing, E. J., Uwimana, A. L., Hernández‐Laín, A., Michotte, A., Al-Hussaini, M. A., Bielle, F., Mawrin, C., Marucci, G., Tesileanu, C. M. S., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac282 · Cited by 30
Donson, A. M., Bertrand, K. C., Riemondy, K. A., Gao, D., Zhuang, Y., Sanford, B. L., Norris, G. A., Chapman, R. J., Fu, R., Willard, N., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad096 · Cited by 28
Li, Q., Zhang, L., Chen, C., Gan, Y., Jiang, L., Li, S., Xiang, W., Ming, Y., Yang, C., & Zhou, J. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.11.012 · Cited by 24
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline
Mohile, N. A., Messersmith, H. J., Gatson, N. T., Hottinger, A. F., Lassman, A. B., Morton, J., Ney, D. E., Nghiemphu, P. L., Olar, A., Olson, J. J., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab279 · Cited by 22
Glioma patient-reported outcomes: patients and clinicians
Peeters, M. C. M., Ottenheijm, G., Bienfait, P., Eekers, D. B. P., Gijtenbeek, A., Hanse, M. C. J., Koekkoek, J. A. F., van Leeuwen, L. L., Tijssen, C. C., Dirven, L., et al. (2021) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2020-002699 · Cited by 9
Self-citationCoomans, M. B., Dirven, L., Aaronson, N. K., Baumert, B. G., van den Bent, M. J., Bottomley, A., Brandes, A. A., Chinot, O. L., Coens, C., Gorlia, T., et al. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa147 · Cited by 3
Self-citation
Cited by
Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system
Wang, C., Xue, Y., Markovic, T., Li, H., Wang, S., Zhong, Y., Du, S., Zhang, Y., Hou, X., Yu, Y., et al. (2025) · Nature Materials · doi:10.1038/s41563-024-02114-5 · Cited by 171
“GBM represents the most aggressive and lethal form of primary brain tumour 53 .”
A self-directed Trojanbot-enzymatic nanobot in neutrobot for active target therapy of glioblastoma
Gao, Y., Mao, M., Li, Y., Xuan, M., Wu, Y., & He, Q. (2025) · Nature Communications · doi:10.1038/s41467-025-60422-z · Cited by 42
Metadata
- Authors
- Weller, M., Wen, P. Y., Chang, S. M., Dirven, L., Lim, M., Monje, M., & Reifenberger, G.
- Venue
- Nature Reviews Disease Primers
- Published
- 2024-05-09
- Volume
- 10
- Issue
- 1
- Pages
- 33-33
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4396762217
- Cited by
- 592
- References
- 264
- FWCI
- 77.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.